• Live operational evaluation of EMVision's portable First Responder device with Royal Flying Doctor Service (RFDS) teams
• Study assesses usability, workflow integration, training requirements, scan success rates, and environmental robustness
• Findings will de-risk operational deployment, inform final commercial device design and support regulatory and commercial pathways

EMVision Medical Devices Limited (ASX:EMV) ('EMVision' or the 'Company') has commenced an aeromedical feasibility and usability study of its First Responder device in collaboration with the Royal Flying Doctor Service (RFDS), Australian Stroke Alliance (ASA) and South Australian Ambulance Service (SAAS). The study will enrol aeromedical retrieval patients and will collect operator feedback and EMVision brain scans including workflow metrics generated from scan procedures. The evaluation focuses on operational feasibility and usability, including integration into aeromedical workflows, in the pre-hospital setting. The study hypothesises that the proposed EMVision First Responder Brain Scanner aeromedical workflow is suitable for use in an emergency aeromedical stroke response. Data will be used to refine commercial product design, training materials and support subsequent clinical and regulatory activities. The study is expected to complete during CY Q1 2026. Early, accurate diagnosis of acute stroke in pre-hospital and remote settings remains a major unmet need. Aeromedical retrievals are challenged by vast distances and inaccessibility of neuroimaging infrastructure in rural and remote areas, thereby preventing timely diagnosis and treatment. EMVision seeks to improve care accessibility and equality in patient outcomes in these settings, through the deployment of a cost-effective, portable and easy-to-use brain scanning device. The First Responder device is designed to empower healthcare teams to make earlier, evidence-based decisions for stroke patients, supporting faster triage, transfer or treatment where it's needed most.

Ongoing capture of usability and operational data over the coming months. Iterative device and workflow refinements based on study findings. Preparation for subsequent data collection, validation and regulatory activities to support First Responder market entry and commercialisation.